Cognitive enhancing drugs, such as cholinesterase inhibitors and methylphenidate, are used to treat cognitive dysfunction in Alzheimer's disease and attention deficit hyperactivity disorder, respectively. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.